Reducing the burden of breast & cervical cancers in emerging economies in the Asia Pacific region like the Philippines is achievable with strategic, targeted, and sustainable intervention and action, according to a report released recently by the APAC Women’s Cancer Coalition .
The APAC WCC report, supported by Roche and published by Economist Impact, examines the burden of breast and cervical cancer in six countries in the Asia Pacific region: India, Indonesia, Malaysia, the Philippines, Thailand, and Vietnam, and identifies market-specific gaps and opportunities for improvement.
Additionally, despite evidence that innovative drugs significantly improve survival rates, delay the progression of disease, and improve the overall quality of life of breast cancer patients, there is only one innovative targeted drug for breast cancer in the Philippine National Formulary .